CF Industries reports Q1 2026 results on May 7, with the stock at $128.04 — right on top of analyst consensus — and a fleet of target increases that hasn't yet convinced the Street to upgrade its ratings.
The analyst activity over the past three weeks tells a coherent story: almost every firm raised its target, but none moved their rating. Goldman Sachs lifted to $132 from $103 on April 14. Morgan Stanley went to $135 from $95 a week earlier. Barclays, the most bullish of the group, now carries a $145 target with an Overweight rating — the outlier in an otherwise neutral-to-cautious consensus. CIBC raised to $128 on April 30, matching almost exactly where the stock is now trading. The mean target across the Street is $120.94, which at the current price implies slightly negative return potential of around -5.5%. That's not a screaming sell signal, but it does mean the rally has already priced in much of what analysts expected. The stock is up 62.8% year-to-date — a remarkable run in a sector not usually associated with momentum.
The positioning data doesn't reflect a lot of conviction in either direction. Short interest is 4.9% of the free float — meaningful but not elevated, and it has been drifting lower over the week, down about 1% from last Tuesday's levels. Days to cover is just 0.5, which means there's no structural overhang of trapped shorts. Borrow availability is loose — cost to borrow has eased to 0.40% APR after touching a brief peak around 0.58% in late April, and with the 52-week lending-pool utilization peak of just 13.4%, the borrow market remains wide open. The short score of 36, sitting in only the 33rd percentile of its universe, confirms this isn't a name where short sellers are pressing hard. Options traders have been tilting bullish: the put/call ratio came in at 0.63, well below its 20-day average of 0.67 and running about 1.4 standard deviations below that mean. Demand for calls is outweighing puts — a reasonable stance given the price momentum, though the PCR 52-week low of 0.44 suggests there's still room for sentiment to get more stretched.
The bull case rests on CF's free cash flow machine and its strategic positioning in low-carbon ammonia. With operating cash flow north of $3 billion and a $19.3 billion market cap, the company generates cash at a rate few commodity producers can match. The EV/EBITDA multiple has actually contracted about 1.6 turns over the past 30 days to 7.0x, while the PE has compressed nearly four points to 10.3x — valuation is becoming cheaper relative to earnings even as the stock rallies. The earnings yield factor scores in the 80th percentile, and EPS momentum ranks in the 91st-to-93rd percentile range across both 30- and 90-day windows. The bears point to the other side of the nitrogen cycle: Chinese urea export risk, a potential H2 2026 demand slowdown, and the possibility that lower European gas prices compress global nitrogen margins. If LNG dynamics shift, CF's cost advantage over European producers narrows. Scotiabank, maintaining Sector Perform, raised its target to $115 — still well below the current price — and Bank of America and Mizuho both carry Underperform ratings, citing the same supply-side risks.
Earnings reaction history is calm. The last three releases produced next-day moves of +2.5%, +1.4%, and +6.0% respectively, all to the upside and none violent. The five-day drift has also been contained. That pattern suggests the market has generally rewarded CF on print day, but the moves have been modest enough that positioning into earnings has rarely been punished. The stock enters tomorrow's release having already gained 4.7% on the week — most of the peer group moved in the same direction, with LYB up 8.8%, DOW up 7.3%, and IPI up 6.9%. UAN was the notable laggard, up just 0.6%, suggesting the nitrogen-specific trade was less consensus than the broader chemicals move.
The setup going into Thursday's print is therefore less about whether CF can beat — the EPS surprise factor at the 68th percentile suggests it usually does — and more about what management says on the supply and pricing outlook for the second half of the year.
See the live data behind this article on ORTEX.
Open CF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
